 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Associations of Newer Cardiac Risk Factors with Chronic Kidney Disease
6 January 2004 | Volume 140 Issue 1 | Page I-26
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
The summary below is from the full report titled "The Prevalence of Nontraditional Risk Factors for Coronary Heart Disease in Patients with Chronic Kidney Disease." It is in the 6 January 2004 issue of Annals of Internal Medicine (volume 140, pages 9-17). The authors are P. Muntner, L.L. Hamm, J.W. Kusek, J. Chen, P.K. Whelton, and J. He.
What is the problem and what is known about it so far?
Compared with people with healthy kidneys, people with chronic kidney disease have more cardiovascular complications, including heart attack and stroke. Traditional risk factors for cardiovascular disease include high blood pressure, diabetes, and abnormal cholesterol levels. Many people with chronic kidney disease have these traditional cardiovascular risk factors. More recently, researchers have identified other "newer" risk factors for cardiovascular disease. The newer risk factors include high blood levels of substances that indicate inflammation: homocysteine, C-reactive protein, and fibrinogen. The blood levels of specific fats are also newer risk factors: low levels of apolipoprotein A1 and high levels of apolipoprotein B or lipoprotein(a). The frequency of these newer cardiovascular risk factors in people with chronic kidney disease is unknown.
Why did the researchers do this particular study?
To examine the frequency of the newer cardiovascular risk factors in people with chronic kidney disease.
Who was studied?
Adults who participated in a national health study in the United States called the Third National Health and Nutrition Examination Survey.
How was the study done?
Using blood tests, the researchers divided people into 3 groups: normal kidneys, mild chronic kidney disease, or severe chronic kidney disease. They then compared the frequency of the newer risk factors among people in the 3 groups.
What did the researchers find?
Kidney disease was associated with lower apolipoprotein A1 levels and with higher levels of apolipoprotein B, apolipoprotein(a), fibrinogen, homocysteine, and C-reactive protein.
What were the limitations of the study?
This study cannot tell us whether these risk factors explain the higher rates of cardiovascular complications in people with chronic kidney disease. It also cannot tell us whether treating these risk factors can decrease cardiovascular complications in people with chronic kidney disease.
What are the implications of the study?
People with chronic kidney disease are more likely to have the newer cardiovascular risk factors than are people with healthy kidneys. Further research is necessary to learn whether changing these risk factors can help to prevent cardiovascular complications.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  M. Chonchol, M. Benderly, and U. Goldbourt Beta-blockers for coronary heart disease in chronic kidney disease Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2274 - 2279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. P. Liew, J. R. Bartholomew, S. Demirjian, J. Michaels, and M. J. Schreiber Jr. Combined Effect of Chronic Kidney Disease and Peripheral Arterial Disease on All-Cause Mortality in a High-Risk Population Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1084 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Stenvinkel, J. J. Carrero, J. Axelsson, B. Lindholm, O. Heimburger, and Z. Massy Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease Patient: How Do New Pieces Fit into the Uremic Puzzle? Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 505 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pereg, A. Tirosh, T. Shochat, D. Hasdai, and for the Metabolic, Lifestyle and Nutrition Assessm Mild renal dysfunction associated with incident coronary artery disease in young males Eur. Heart J., January 2, 2008; 29(2): 198 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. H. de Boer, B. C. Astor, H. Kramer, W. Palmas, S. L. Seliger, M. G. Shlipak, D. S. Siscovick, M. Y. Tsai, and B. Kestenbaum Lipoprotein Abnormalities Associated with Mild Impairment of Kidney Function in the Multi-Ethnic Study of Atherosclerosis Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 125 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Burling, J. Ng, H. Thein, J. Ly, M.R. Marshall, and P. Gow Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort Lupus, October 1, 2007; 16(10): 830 - 837. [Abstract] [PDF]
|
|
|
|
 |
|
 S. F. E. Praet and L. J. C. van Loon Optimizing the therapeutic benefits of exercise in Type 2 diabetes J Appl Physiol, October 1, 2007; 103(4): 1113 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Chonchol, V. Aboyans, P. Lacroix, G. Smits, T. Berl, and M. Laskar Long-term outcomes after coronary artery bypass grafting: Preoperative kidney function is prognostic J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 683 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. Glynn, D. Reddan, J. Newell, J. Hinde, B. Buckley, and A. W. Murphy Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: a West of Ireland community-based cohort study Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2586 - 2594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Maaravi, M. Bursztyn, R. Hammerman-Rozenberg, and J. Stessman Glomerular filtration rate estimation and mortality in an elderly population QJM, July 1, 2007; 100(7): 441 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Ozsoy, W. A. van der Steeg, J. J. P. Kastelein, L. Arisz, and M. G. Koopman Dyslipidaemia as predictor of progressive renal failure and the impact of treatment with atorvastatin Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1578 - 1586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. DuBose Jr. American Society of Nephrology Presidential Address 2006: Chronic Kidney Disease as a Public Health Threat--New Strategy for a Growing Problem J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1038 - 1045. [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Ensrud, L.-Y. Lui, B. C. Taylor, A. Ishani, M. G. Shlipak, K. L. Stone, J. A. Cauley, S. A. Jamal, D. M. Antoniucci, S. R. Cummings, et al. Renal Function and Risk of Hip and Vertebral Fractures in Older Women Arch Intern Med, January 22, 2007; 167(2): 133 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Odden, G. M. Chertow, L. F. Fried, A. B. Newman, S. Connelly, S. Angleman, T. B. Harris, E. M. Simonsick, M. G. Shlipak, and for the HABC Study Cystatin C and Measures of Physical Function in Elderly Adults: The Health, Aging, and Body Composition (HABC) Study Am. J. Epidemiol., December 15, 2006; 164(12): 1180 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Wannamethee, A. G. Shaper, G. D.O. Lowe, L. Lennon, A. Rumley, and P. H. Whincup Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers Eur. Heart J., December 2, 2006; 27(24): 2975 - 2981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Coca, H. M. Krumholz, A. X. Garg, and C. R. Parikh Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA, September 20, 2006; 296(11): 1377 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. de Rekeneire, R. Peila, J. Ding, L. H. Colbert, M. Visser, R. I. Shorr, S. B. Kritchevsky, L. H. Kuller, E. S. Strotmeyer, A. V. Schwartz, et al. Diabetes, Hyperglycemia, and Inflammation in Older Individuals: The Health, Aging and Body Composition study Diabetes Care, August 1, 2006; 29(8): 1902 - 1908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Solomon, M. M. Rice, K. A. Jablonski, P. Jose, M. Domanski, M. Sabatine, B. J. Gersh, J. Rouleau, M. A. Pfeffer, E. Braunwald, et al. Renal Function and Effectiveness of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Chronic Stable Coronary Disease in the Prevention of Events with ACE inhibition (PEACE) Trial Circulation, July 4, 2006; 114(1): 26 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ulrich, G. H. Heine, P. Garcia, B. Reichart, T. Georg, M. Krause, H. Kohler, and M. Girndt Increased expression of monocytic angiotensin-converting enzyme in dialysis patients with cardiovascular disease Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1596 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. T. Nguyen and A. G. Stack Ethnic Disparities in Cardiovascular Risk Factors and Coronary Disease Prevalence among Individuals with Chronic Kidney Disease: Findings from the Third National Health and Nutrition Examination Survey J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1716 - 1723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Menon, M. J. Sarnak, T. Greene, X. Wang, A. A. Pereira, G. J. Beck, J. W. Kusek, J. Selhub, A. J. Collins, A. S. Levey, et al. Relationship Between Homocysteine and Mortality in Chronic Kidney Disease Circulation, March 28, 2006; 113(12): 1572 - 1577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Maaravi, M. Bursztyn, R. Hammerman-Rozenberg, A. Cohen, and J. Stessman Moderate renal insufficiency at 70 years predicts mortality QJM, February 1, 2006; 99(2): 97 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Fox, M. G. Larson, R. S. Vasan, C.-Y. Guo, H. Parise, D. Levy, E. P. Leip, C. J. O'Donnell, R. B. D'Agostino Sr., and E. J. Benjamin Cross-Sectional Association of Kidney Function with Valvular and Annular Calcification: The Framingham Heart Study J. Am. Soc. Nephrol., February 1, 2006; 17(2): 521 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Schrier Role of Diminished Renal Function in Cardiovascular Mortality: Marker or Pathogenetic Factor? J. Am. Coll. Cardiol., January 3, 2006; 47(1): 1 - 8. [Abstract] [Full Text]
|
|
|
|
|
|
N. A. Khan, I. Ma, C. R. Thompson, K. Humphries, D. N. Salem, M. J. Sarnak, and A. Levin Kidney Function and Mortality among Patients with Left Ventricular Systolic Dysfunction J. Am. Soc. Nephrol., January 1, 2006; 17(1): 244 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shlipak and C. Stehman-Breen Observational Research Databases in Renal Disease J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3477 - 3484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Shlipak, L. F. Fried, M. Cushman, T. A. Manolio, D. Peterson, C. Stehman-Breen, A. Bleyer, A. Newman, D. Siscovick, and B. Psaty Cardiovascular Mortality Risk in Chronic Kidney Disease: Comparison of Traditional and Novel Risk Factors JAMA, April 13, 2005; 293(14): 1737 - 1745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Levin Cystatin C, Serum Creatinine, and Estimates of Kidney Function: Searching for Better Measures of Kidney Function and Cardiovascular Risk Ann Intern Med, April 5, 2005; 142(7): 586 - 588. [Full Text] [PDF]
|
|
|
|
|
|
G. A. Knoll, P. S. Wells, D. Young, S. L. Perkins, R. M. Pilkey, J. J. Clinch, and M. A. Rodger Thrombophilia and the Risk for Hemodialysis Vascular Access Thrombosis J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1108 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Muntner, J. He, B. C. Astor, A. R. Folsom, and J. Coresh Traditional and Nontraditional Risk Factors Predict Coronary Heart Disease in Chronic Kidney Disease: Results from the Atherosclerosis Risk in Communities Study J. Am. Soc. Nephrol., February 1, 2005; 16(2): 529 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Kestenbaum, J. N. Sampson, K. D. Rudser, D. J. Patterson, S. L. Seliger, B. Young, D. J. Sherrard, and D. L. Andress Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease J. Am. Soc. Nephrol., February 1, 2005; 16(2): 520 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Baggio, A. Budakovic, E. Perissinotto, S. Maggi, S. Cantaro, G. Enzi, F. Grigoletto, and for the ILSA Working Group Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA) Nephrol. Dial. Transplant., January 1, 2005; 20(1): 114 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Go, G. M. Chertow, D. Fan, C. E. McCulloch, and C.-y. Hsu Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization N. Engl. J. Med., September 23, 2004; 351(13): 1296 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Knight, E. B. Rimm, J. K. Pai, K. M. Rexrode, C. C. Cannuscio, J. E. Manson, M. J. Stampfer, and G. C. Curhan Kidney Dysfunction, Inflammation, and Coronary Events: A Prospective Study J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1897 - 1903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Appel Beyond (or Back to) Traditional Risk Factors: Preventing Cardiovascular Disease in Patients with Chronic Kidney Disease Ann Intern Med, January 6, 2004; 140(1): 60 - 61. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
